Role of medical reaction in management of inappropriate ventricular arrhythmia diagnosis: the inappropriate Therapy and HOme monitoRiNg (THORN) registry.


Journal

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
ISSN: 1532-2092
Titre abrégé: Europace
Pays: England
ID NLM: 100883649

Informations de publication

Date de publication:
01 Apr 2019
Historique:
received: 07 06 2018
accepted: 05 11 2018
pubmed: 4 1 2019
medline: 6 10 2020
entrez: 4 1 2019
Statut: ppublish

Résumé

Implantable cardioverter-defibrillators (ICDs) reduce sudden cardiac death in selected patients but inappropriate ICD shocks have been associated with increased mortality. The THORN registry aims to describe the rate of inappropriate ventricular arrhythmia diagnoses and therapies in patients followed by remote monitoring, as well as the following delay to next patient contact (DNPC). One thousand eight hundred and eighty-two patients issued from a large remote monitoring database first implanted with an ICD for primary or secondary prevention in 110 French hospitals from 2007 to 2014 constitute the THORN population. Among them, 504 patients were additionally followed prospectively for evaluation of the DNPC. Eight hundred and ninety-five out of 1551 (58%) patients had ischaemic heart disease and 358/771 (46%) were implanted for secondary prevention. During 13.7 ± 3.4 months of follow-up, the prevalence of first inappropriate diagnosis in a ventricular arrhythmia zone with enabled therapy was 162/1882 (9%). Among those patients, 122/162 (75%) suffered at least one inappropriate therapy and 58/162 (36%) at least one inappropriate shock. Eighty-three out of 162 (51%) of first inappropriate diagnosis occurred during the first 4 months following implantation. The median DNPC was 8 days (interquartile range 1-26). At least one other day with recording of an inappropriate diagnosis of the same cause occurred in 13/43 (30%) of available DNPC periods, with an inappropriate therapy in 7/13 (54%). Inappropriate diagnoses occurred in 9% of patients implanted with an ICD during the first 14 months. The DNPC after inadequate ventricular arrhythmia diagnoses remains long in daily practice and should be optimized. NCT01594112.

Identifiants

pubmed: 30605510
pii: 5272353
doi: 10.1093/europace/euy284
pmc: PMC6452297
doi:

Banques de données

ClinicalTrials.gov
['NCT01594112']

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

607-615

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press on behalf of the European Society of Cardiology.

Références

N Engl J Med. 2002 Mar 21;346(12):877-83
pubmed: 11907286
N Engl J Med. 2004 May 20;350(21):2151-8
pubmed: 15152060
Am Heart J. 2005 Apr;149(4):664-9
pubmed: 15990750
J Am Coll Cardiol. 2008 May 27;51(21):e1-62
pubmed: 18498951
J Am Coll Cardiol. 2008 Aug 12;52(7):541-50
pubmed: 18687248
Circulation. 2010 Jul 27;122(4):325-32
pubmed: 20625110
J Am Coll Cardiol. 2011 Mar 8;57(10):1181-9
pubmed: 21255955
J Am Coll Cardiol. 2011 Feb 1;57(5):556-62
pubmed: 21272746
N Engl J Med. 2012 Dec 13;367(24):2275-83
pubmed: 23131066
Eur Heart J. 2013 Feb;34(8):605-14
pubmed: 23242192
JAMA. 2013 May 8;309(18):1903-11
pubmed: 23652522
J Cardiovasc Electrophysiol. 2014 Jul;25(7):763-70
pubmed: 24602062
Lancet. 2014 Aug 16;384(9943):583-590
pubmed: 25131977
Can J Cardiol. 2015 Mar;31(3):270-7
pubmed: 25746019
Heart Rhythm. 2015 Jul;12(7):e69-100
pubmed: 25981148
J Am Coll Cardiol. 2015 Jun 23;65(24):2591-2600
pubmed: 25983009
Europace. 2016 Feb;18(2):159-83
pubmed: 26585598
Heart Rhythm. 2017 Feb;14(2):211-217
pubmed: 27989789
N Engl J Med. 1997 Nov 27;337(22):1576-83
pubmed: 9411221

Auteurs

Tilman Perrin (T)

Department of Cardiology, Centre Hospitalier Universitaire La Timone, Marseille, France.

Serge Boveda (S)

Department of Cardiology, Clinique Pasteur, Toulouse, France.

Pascal Defaye (P)

Department of Cardiology, Centre Hospitalier Universitaire Albert Michalon, Grenoble, France.

Arnaud Rosier (A)

Department of Cardiology, Hôpital Privé Jacques Cartier, Massy, France.

Nicolas Sadoul (N)

Department of Cardiology, Centre Hospitalier Universitaire Brabois, Nancy, France.

Pierre Bordachar (P)

Department of Cardiology, Centre Hospitalier Universitaire de Haut-Lévêque, Pessac, France.

Didier Klug (D)

Department of Cardiology, Centre Hospitalier Régional Universitaire de Lille, Lille, France.

Philippe Ritter (P)

Department of Cardiology, Centre Hospitalier Universitaire de Haut-Lévêque, Pessac, France.

Mohamed Belhameche (M)

Department of Cardiology, Centre Hospitalier de Marne-la-Vallée, Jossigny, France.

Dominique Babuty (D)

Department of Cardiology, Centre Hospitalier Régional Universitaire Trousseau, Chambray-lès-Tours, France.

Jacques Mansourati (J)

Department of Cardiology, Centre Régional Hospitalier Universitaire Brest, Hôpital de La Cavale Blanche, Brest, France.

Arnaud Lazarus (A)

Department of Cardiology, Clinique Ambroise Paré, Neuilly-sur-Seine, France.

Jean-Claude Deharo (JC)

Department of Cardiology, Centre Hospitalier Universitaire La Timone, Marseille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH